StockMacro
Menu

Idexx Laboratories

$676.21 +21% in 6 monthsMarket cap $53.3B

IDXX on XNAS, Health Care, Idexx Laboratories Inc, job postings

Measures activity, not value. Not investment advice.

Shares jumped 22% in a month but are still down 1.9% over 12 months.

  • GoodNet profit rose 15% to $1.2B over the last 12 months

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx derives roughly 35% of its revenue from outside the United States.

Industry
In vitro & in vivo diagnostic substances (Health Care)
Employees
11,000
Website
idexx.com
Listed
Nasdaq, US
Last results
2 Nov 2026
Next results
expected around 1 Feb 2027 (an estimate: a year ago it reported on 2 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $1.2B, net income $317.1M.
Quarter to 31 Dec 2021: revenue $801.1M, net income $162.8MQuarter to 31 Dec 2021: revenue $801.1M, net income $162.8MQuarter to 31 Mar 2022: revenue $836.5M, net income $194.0MQuarter to 31 Mar 2022: revenue $836.5M, net income $194.0MQuarter to 30 Jun 2022: revenue $860.5M, net income $132.0MQuarter to 30 Jun 2022: revenue $860.5M, net income $132.0MQuarter to 30 Sep 2022: revenue $841.7M, net income $180.9MQuarter to 30 Sep 2022: revenue $841.7M, net income $180.9MQuarter to 31 Dec 2022: revenue $828.6M, net income $172.2MQuarter to 31 Dec 2022: revenue $828.6M, net income $172.2MQuarter to 31 Mar 2023: revenue $900.2M, net income $214.1MQuarter to 31 Mar 2023: revenue $900.2M, net income $214.1MQuarter to 30 Jun 2023: revenue $943.6M, net income $224.2MQuarter to 30 Jun 2023: revenue $943.6M, net income $224.2MQuarter to 30 Sep 2023: revenue $915.5M, net income $212.2MQuarter to 30 Sep 2023: revenue $915.5M, net income $212.2MQuarter to 31 Dec 2023: revenue $901.6M, net income $194.5MQuarter to 31 Dec 2023: revenue $901.6M, net income $194.5MQuarter to 31 Mar 2024: revenue $964.1M, net income $235.6MQuarter to 31 Mar 2024: revenue $964.1M, net income $235.6MQuarter to 30 Jun 2024: revenue $1.0B, net income $203.3MQuarter to 30 Jun 2024: revenue $1.0B, net income $203.3MQuarter to 30 Sep 2024: revenue $975.5M, net income $232.8MQuarter to 30 Sep 2024: revenue $975.5M, net income $232.8MQuarter to 31 Dec 2024: revenue $954.3M, net income $216.1MQuarter to 31 Dec 2024: revenue $954.3M, net income $216.1MQuarter to 31 Mar 2025: revenue $998.4M, net income $242.7MQuarter to 31 Mar 2025: revenue $998.4M, net income $242.7MQuarter to 30 Jun 2025: revenue $1.1B, net income $294.0MQuarter to 30 Jun 2025: revenue $1.1B, net income $294.0MQuarter to 30 Sep 2025: revenue $1.1B, net income $274.6MQuarter to 30 Sep 2025: revenue $1.1B, net income $274.6MQuarter to 31 Dec 2025: revenue $1.1B, net income $248.2MQuarter to 31 Dec 2025: revenue $1.1B, net income $248.2MQuarter to 31 Mar 2026: revenue $1.1B, net income $278.4MQuarter to 31 Mar 2026: revenue $1.1B, net income $278.4MQuarter to 30 Jun 2026: revenue $1.2B, net income $338.4MQuarter to 30 Jun 2026: revenue $1.2B, net income $338.4MQuarter to 30 Sep 2026: revenue $1.2B, net income $317.1MQuarter to 30 Sep 2026: revenue $1.2B, net income $317.1M
31 Dec 2021RevenueNet incometallest bar $1.2B30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$1.2B$317.1M
30 Jun 2026$1.2B$338.4M
31 Mar 2026$1.1B$278.4M
31 Dec 2025$1.1B$248.2M
30 Sep 2025$1.1B$274.6M
30 Jun 2025$1.1B$294.0M
31 Mar 2025$998.4M$242.7M
31 Dec 2024$954.3M$216.1M
30 Sep 2024$975.5M$232.8M
30 Jun 2024$1.0B$203.3M
31 Mar 2024$964.1M$235.6M
31 Dec 2023$901.6M$194.5M
30 Sep 2023$915.5M$212.2M
30 Jun 2023$943.6M$224.2M
31 Mar 2023$900.2M$214.1M
31 Dec 2022$828.6M$172.2M
30 Sep 2022$841.7M$180.9M
30 Jun 2022$860.5M$132.0M
31 Mar 2022$836.5M$194.0M
31 Dec 2021$801.1M$162.8M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $4.7B $4.2B
Revenue growthRevenue of the last 12 months compared with the 12 months before. +12% -1.5%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. $1.2B $1.0B
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). $14.84 $12.61
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 62.7% 61.7% 51.3%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. 32.3% 31.3% -9.6%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. 25.4% 24.7% -15.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. 68.9% -40.2%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. $1.3B $963.6M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $197.5M $208.2M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – $524.8M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – $316.7M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 0.22
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $23.72
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. 45.1 24.7
P/SPrice to sales: market cap divided by revenue of the last 12 months. 11.4 3.6
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 3.6
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 28.5 2.3

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
Idexx LaboratoriesIDXX (this company) $53.3B45.111.4+12%25.4%
LantheusLNTH $6.7B24.74.3+2.4%17.3%
Becton, Dickinson andBDX $58.0B61.62.8+5.2%4.5%
Edwards LifesciencesEW $58.6B57.38.8+13%15.3%
Boston ScientificBSX $60.8B17.42.9+8.9%16.6%
Teva Pharmaceutical IndustriesTEVA $45.8B90.53.3-16%3.6%

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$28.6M

bought $0, sold $28.6M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-0.9%

1,261 13F filers vs 1,272

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

93%

73.0M shares held by 13F filers (30 Sep 2026) of 78.8M outstanding (28 Oct 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

3.0%

2.4M shares sold short (30 Oct 2026) of 78.8M outstanding (28 Oct 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.5

2.4M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+22%

1.9M shares sold short in the report before, 2.4M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

50%

50% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

230

Tracked since 21 Nov 2026

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

Tracking started 21 Nov 2026; the change shows after 30 days.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

-45%

12 vs 22 applications

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+9.9%

$1.2B vs $1.1B (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

-7.0%

$28.9M vs $31.1M (quarter ended 30 Sep 2026)

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$2.1M

the 12 months before: $1.7M

Lobbying What the company reported spending on federal lobbying over the last four quarters.

–

No data for this company

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

44

44 articles in the last 7 days; its usual week has 4.5 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

9.8×

44 articles in the last 7 days; its usual week has 4.5.

Price $676.21 on 20 Nov 2026, -1.9% over 12 months (12-month range $504.70 to $766.68)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $58.4M in the last 12 months (the 12 months before: -$50.1M).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 12 published in the last 12 months, -45% on the 12 months before.
Revenue per quarter. Revenue $1.2B in the latest quarter, +9.9% on a year earlier.
Capital spending per quarter. Capital spending $28.9M in the latest quarter, -7.0% on a year earlier.
Institutional holders (13F filers). 1,261 13F filers reported holding it in the latest 13F quarter, +3.1% on a year earlier.
Federal obligations. Federal obligations: $1.9M published in the last 12 months, +20% on the 12 months before.
Lobbying spend. Lobbying spend: $0 published in the last 12 months.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
26 Mar 20268-K and other filingsDirector or officer change
13 Feb 20268-K and other filingsDirector or officer change
13 Jan 20268-K and other filingsDirector or officer change
13 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Oct 20258-K and other filingsDirector or officer change
14 Aug 2025Sharp changeMany funds opening a new position: many funds opening a new position, 175 vs usual 78.50 (2025-06-30); 2.6x the same period a year earlier
10 Jul 20258-K and other filingsDirector or officer change
10 Jul 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 Feb 20258-K and other filingsDirector or officer change
12 Dec 20248-K and other filingsDirector or officer change
21 Nov 20248-K and other filingsDirector or officer change
12 Nov 20248-K and other filingsDirector or officer change
12 Nov 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
10 May 20248-K and other filingsDirector or officer change
10 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
7 Dec 20238-K and other filingsDirector or officer change
7 Dec 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Jul 20238-K and other filingsDirector or officer change
12 Jul 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Aug 2022Sharp changeShort interest spike: short interest spike, 2.0M vs usual 869K (2022-08-15); 2.3x the same period a year earlier
16 Aug 2022Sharp changeShort interest spike: short interest spike, 1.7M vs usual 865K (2022-07-29); 2.0x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 1.9M vs usual 849K (2022-07-15); 2.2x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 2.0M vs usual 849K (2022-06-30); 2.4x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 2.0M vs usual 849K (2022-06-15); 2.3x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 1.8M vs usual 844K (2022-05-31); 2.1x the same period a year earlier
31 May 2022Sharp changeShort interest spike: short interest spike, 1.4M vs usual 842K (2022-05-13); 2.0x the same period a year earlier
19 Jan 2022Lobbying filinglobbying engagement terminated (COZEN O'CONNOR PUBLIC STRATEGIES)
Insider net buying (open market)
Month from 1 Dec 2021: -$2.9M published
Month from 1 Feb 2022: -$127K published
Month from 1 Nov 2022: -$15.5M published
Month from 1 Dec 2022: -$2.9M published
Month from 1 Feb 2023: -$3.1M published
Month from 1 May 2023: -$12.3M published
Month from 1 Aug 2023: -$8.2M published
Month from 1 Sep 2023: -$18.6M published
Month from 1 Dec 2023: -$9.7M published
Month from 1 Feb 2024: -$24.9M published
Month from 1 Mar 2024: -$5.3M published
Month from 1 May 2024: -$108K published
Month from 1 Sep 2024: -$235K published
Month from 1 Nov 2024: -$145K published
Month from 1 Feb 2025: -$6.0M published
Month from 1 May 2025: -$3.2M published
Month from 1 Aug 2025: -$34.3M published
Month from 1 Nov 2025: -$6.6M published
Month from 1 Feb 2026: -$13.4M published
Month from 1 Mar 2026: -$16.5M published
Month from 1 Sep 2026: -$1.2M published
Month from 1 Nov 2026: -$27.4M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 3 published
Quarter from 1 Apr 2022: 5 published
Quarter from 1 Jul 2022: 8 published
Quarter from 1 Oct 2022: 2 published
Quarter from 1 Jan 2023: 5 published
Quarter from 1 Apr 2023: 7 published
Quarter from 1 Jul 2023: 3 published
Quarter from 1 Oct 2023: 3 published
Quarter from 1 Jan 2024: 2 published
Quarter from 1 Apr 2024: 4 published
Quarter from 1 Jul 2024: 6 published
Quarter from 1 Oct 2024: 5 published
Quarter from 1 Jan 2025: 3 published
Quarter from 1 Apr 2025: 4 published
Quarter from 1 Jul 2025: 9 published
Quarter from 1 Oct 2025: 6 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Apr 2026: 2 published
Quarter from 1 Jul 2026: 8 published
Quarter from 1 Oct 2026: 1 published
Revenue per quarter
Quarter ended 31 Dec 2021: $801.1M, +11% on a year earlier; public on 17 Feb 2022
Quarter ended 31 Mar 2022: $836.5M, +7.6% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $860.5M, +4.2% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $841.7M, +3.9% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $828.6M, +3.4% on a year earlier; public on 17 Feb 2023
Quarter ended 31 Mar 2023: $900.2M, +7.6% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $943.6M, +9.7% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2023: $915.5M, +8.8% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $901.6M, +8.8% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $964.1M, +7.1% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $1.0B, +6.4% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $975.5M, +6.6% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $954.3M, +5.8% on a year earlier; public on 22 Feb 2025
Quarter ended 31 Mar 2025: $998.4M, +3.6% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $1.1B, +11% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $1.1B, +13% on a year earlier; public on 4 Nov 2025
Quarter ended 31 Dec 2025: $1.1B, +14% on a year earlier; public on 21 Feb 2026
Quarter ended 31 Mar 2026: $1.1B, +14% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $1.2B, +9.7% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $1.2B, +9.9% on a year earlier; public on 3 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $31.8M, +124% on a year earlier; public on 17 Feb 2022
Quarter ended 31 Mar 2022: $31.8M, +58% on a year earlier; public on 5 May 2022
Quarter ended 30 Jun 2022: $30.1M, +33% on a year earlier; public on 3 Aug 2022
Quarter ended 30 Sep 2022: $37.7M, -16% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $49.2M, +55% on a year earlier; public on 17 Feb 2023
Quarter ended 31 Mar 2023: $39.5M, +24% on a year earlier; public on 3 May 2023
Quarter ended 30 Jun 2023: $27.5M, -8.7% on a year earlier; public on 2 Aug 2023
Quarter ended 30 Sep 2023: $34.1M, -9.5% on a year earlier; public on 2 Nov 2023
Quarter ended 31 Dec 2023: $32.6M, -34% on a year earlier; public on 23 Feb 2024
Quarter ended 31 Mar 2024: $30.3M, -23% on a year earlier; public on 2 May 2024
Quarter ended 30 Jun 2024: $33.3M, +21% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $28.1M, -18% on a year earlier; public on 1 Nov 2024
Quarter ended 31 Dec 2024: $29.3M, -10% on a year earlier; public on 22 Feb 2025
Quarter ended 31 Mar 2025: $30.0M, -0.8% on a year earlier; public on 2 May 2025
Quarter ended 30 Jun 2025: $34.1M, +2.4% on a year earlier; public on 5 Aug 2025
Quarter ended 30 Sep 2025: $31.1M, +11% on a year earlier; public on 4 Nov 2025
Quarter ended 31 Dec 2025: $29.4M, +0.6% on a year earlier; public on 21 Feb 2026
Quarter ended 31 Mar 2026: $32.0M, +6.5% on a year earlier; public on 6 May 2026
Quarter ended 30 Jun 2026: $24.6M, -28% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $28.9M, -7.0% on a year earlier; public on 3 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 977; public on 14 Feb 2022
31 Mar 2022 report: 955; public on 16 May 2022
30 Jun 2022 report: 899; public on 15 Aug 2022
30 Sep 2022 report: 832; public on 14 Nov 2022
31 Dec 2022 report: 911; public on 14 Feb 2023
31 Mar 2023 report: 983; public on 15 May 2023
30 Jun 2023 report: 976; public on 14 Aug 2023
30 Sep 2023 report: 978; public on 14 Nov 2023
31 Dec 2023 report: 1,065; public on 14 Feb 2024
31 Mar 2024 report: 1,080; public on 15 May 2024
30 Jun 2024 report: 1,052; public on 14 Aug 2024
30 Sep 2024 report: 1,048; public on 14 Nov 2024
31 Dec 2024 report: 1,063; public on 14 Feb 2025
31 Mar 2025 report: 1,080; public on 15 May 2025
30 Jun 2025 report: 1,182; public on 14 Aug 2025
30 Sep 2025 report: 1,223; public on 14 Nov 2025
31 Dec 2025 report: 1,330; public on 17 Feb 2026
31 Mar 2026 report: 1,285; public on 15 May 2026
30 Jun 2026 report: 1,272; public on 14 Aug 2026
30 Sep 2026 report: 1,261; public on 16 Nov 2026
Federal obligations
Month from 1 Nov 2021: $70K published
Month from 1 Dec 2021: $236K published
Month from 1 Jan 2022: $64K published
Month from 1 Feb 2022: $19K published
Month from 1 Mar 2022: $135K published
Month from 1 Apr 2022: $113K published
Month from 1 May 2022: $178K published
Month from 1 Jun 2022: $86K published
Month from 1 Jul 2022: $93K published
Month from 1 Aug 2022: $123K published
Month from 1 Sep 2022: $36K published
Month from 1 Oct 2022: $208K published
Month from 1 Nov 2022: $187K published
Month from 1 Dec 2022: $149K published
Month from 1 Jan 2023: $6K published
Month from 1 Feb 2023: $80K published
Month from 1 Mar 2023: $325K published
Month from 1 Apr 2023: $94K published
Month from 1 May 2023: $121K published
Month from 1 Jun 2023: $86K published
Month from 1 Jul 2023: $151K published
Month from 1 Aug 2023: $44K published
Month from 1 Sep 2023: $65K published
Month from 1 Oct 2023: $46K published
Month from 1 Nov 2023: $57K published
Month from 1 Dec 2023: $148K published
Month from 1 Jan 2024: $100K published
Month from 1 Feb 2024: $51K published
Month from 1 Mar 2024: $264K published
Month from 1 Apr 2024: $167K published
Month from 1 May 2024: $254K published
Month from 1 Jun 2024: $25K published
Month from 1 Jul 2024: $43K published
Month from 1 Aug 2024: $82K published
Month from 1 Sep 2024: $243K published
Month from 1 Oct 2024: $101K published
Month from 1 Nov 2024: $199K published
Month from 1 Dec 2024: $266K published
Month from 1 Jan 2025: $69K published
Month from 1 Feb 2025: $59K published
Month from 1 Mar 2025: $318K published
Month from 1 Apr 2025: $42K published
Month from 1 May 2025: $278K published
Month from 1 Jun 2025: $142K published
Month from 1 Jul 2025: -$18K published
Month from 1 Aug 2025: $261K published
Month from 1 Sep 2025: $101K published
Month from 1 Oct 2025: $2K published
Month from 1 Nov 2025: $28K published
Month from 1 Dec 2025: $288K published
Month from 1 Jan 2026: -$17K published
Month from 1 Feb 2026: -$31K published
Month from 1 Mar 2026: $246K published
Month from 1 Apr 2026: $511K published
Month from 1 May 2026: $123K published
Month from 1 Jun 2026: $608K published
Month from 1 Jul 2026: $3K published
Month from 1 Aug 2026: $48K published
Month from 1 Sep 2026: $76K published
Month from 1 Oct 2026: -$7K published
Month from 1 Nov 2026: $13K published
Lobbying spend
Quarter from 1 Jan 2022: $50K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $27.4M (5 Nov 2026), 10× its normal reading; higher than 98% of its own history.
  • Insider net buying (open market): Insiders sold a net $58.4M in the last 12 months (the 12 months before: -$50.1M).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 12 published in the last 12 months, -45% on the 12 months before.
  • Revenue per quarter: Revenue $1.2B in the latest quarter, +9.9% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Last 90 days: 5 sales, $28.6M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
5 Nov 2026Sharon E. UnderbergEVP, GC & Corporate SecretarySellafter exercising options8,906$688.59$6.1MForm 4
5 Nov 2026Jonathan Jay MazelskyExecutive Chair of the BoardSellafter exercising options25,140$703.19$17.7MForm 4
5 Nov 2026Michael LaneExecutive Vice PresidentSell3,979$688.64$2.7MForm 4
5 Nov 2026Daniel M JuniusDirectorSell1,200$704.07$845KForm 4
9 Sep 2026Lawrence D KingsleyDirectorSellafter exercising options2,203$532.08$1.2MForm 4
5 Mar 2026Nimrata HuntExecutive Vice PresidentSell1,758$634.57$1.1MForm 4
2 Mar 2026Jonathan Jay MazelskyPresident and CEOSellafter exercising options23,326$657.55$15.3MForm 4
27 Feb 2026Nimrata HuntExecutive Vice PresidentSell2,693$661.54$1.8MForm 4

1,261 institutions reported shares at the end of Q3 2026, 93% of the shares outstanding; 93 opened a position, 108 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
BlackRock, Inc.8.1M10.3%$4.2B-70K-0.9%
Vanguard Capital Management LLC5.2M6.55%$2.7B+4,701+0.1%
Vanguard Portfolio Management LLC4.0M5.02%$2.1B+59K+1.5%
State Street Corp3.8M4.77%$2.0B+13K+0.3%
Invesco Ltd.3.4M4.28%$1.8B-238K-6.6%
Geode Capital Management, LLC2.6M3.33%$1.4B+58K+2.3%
Bamco Inc1.8M2.26%$930.8M-194K-9.8%
Morgan Stanley1.4M1.74%$717.7M+18K+1.3%
Arrowstreet Capital, Limited Partnership1.4M1.73%$709.9M+292K+27%
Goldman Sachs Group Inc1.2M1.49%$614.4M+438K+59%

Company events

All 33 company events

In 12 months: 3 director or officer changes. Results releases and routine reports are left out.

FiledWhat happenedSource
26 Mar 2026Director or officer change8-K
13 Feb 2026Director or officer change8-K
13 Jan 2026Director or officer change8-K
13 Nov 2025Signed a major agreementSame filing: took on new debt8-K
7 Oct 2025Director or officer change8-K
10 Jul 2025Director or officer change8-K
14 Feb 2025Director or officer change8-K
12 Dec 2024Director or officer change8-K

230 open postings; careers site tracked since 21 Nov 2026. Most in Sales & business development 9%, Customer success & support 8%, Marketing & communications 7%, Operations & administration 6%.

PostedJobLocation
20 Nov 2026Area Sales TrainerSales & business developmentVirtual United States
20 Nov 2026Software Program ManagerProgram & project managementWestbrook, ME
20 Nov 2026Senior Manager of Revenue OperationsSales & business developmentWestbrook, ME; Virtual Massachusetts; Virtual New Hampshire
20 Nov 2026Software Trainer - Veterinary Software - USSoftware engineeringVirtual United States
20 Nov 2026Field Sales Veterinary Diagnostics Lincoln, NESales & business developmentLincoln, NE
20 Nov 2026Lab Employee Molecular BiologyKuopio, Finland
20 Nov 2026Sample Management Technician - Early ShiftWetherby, United Kingdom
20 Nov 2026Senior Process EngineerProcess engineering (semiconductor / materials)Westbrook, ME

Reported lobbying spend: $50K in Q4 2021, $50K in Q3 2021. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Oct 2021EndedCozen O'Connor Public Strategiesfor IdexxContaminant monitoring and testingEnvironmentFiling
29 Jun 2020NewCozen O'Connor Public Strategiesfor IdexxContaminant monitoring and testingEnvironmentFiling

Layoff notices

All 1 layoff notices

No notice in 12 months; the latest is dated 1 Aug 2021. State WARN notices.

NoticeSiteWorkersJobs endSource
1 Aug 2021IDEXX LaboratoriesTotowa, NJ681 Nov 2021Notice

The 5 newest of 272 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

1 Sep 2021confirmed

Confirmed across sources Filings + Financials and Layoff notices and Short interest and volume

Idexx Laboratories (IDXX): reported revenue of $826.1M for the quarter ended 30 Jun 2021, 1.3× the same quarter last year; it also filed a WARN layoff notice covering 68 workers within 30 days (Totowa, NJ); and it had 1.3M shares sold short in the 15 Sep 2021 report, 1.0× the same report last year. Three unrelated kinds of activity within 56 days.

  • Financials: Quarterly revenue change, became public on 3 Aug 2021
  • Layoff notices: WARN layoff notice, became public on 1 Sep 2021
  • Short interest and volume: Short interest spike, became public on 25 Sep 2021
2019-06-30: $620.1M2019-09-30: $605.3M2019-12-31: $605.4M2020-03-31: $626.3M2020-06-30: $637.6M2020-09-30: $721.8M2020-12-31: $720.9M2021-03-31: $777.7M2021-06-30: $826.1M
The quarter ended 30 Jun 2021 against the 8 quarters before it. this quarterearliernormal: $632.0M
See the evidence (3 changes)

Financials: Quarterly revenue change became public on 3 Aug 2021

Idexx Laboratories reported revenue of $826.1M for the quarter ended 30 Jun 2021, 1.3× the same quarter last year.

This period
$826.1M (the quarter ended 30 Jun 2021)
Normal quarter (median of 8 earlier)
$632.0M
Typical spread (median absolute deviation)
$26.6M
How far from its usual level
+3.1
Same quarter last year
$637.6M
History used
4,383 days
2019-06-30: $620.1M2019-09-30: $605.3M2019-12-31: $605.4M2020-03-31: $626.3M2020-06-30: $637.6M2020-09-30: $721.8M2020-12-31: $720.9M2021-03-31: $777.7M2021-06-30: $826.1M
the quarter ended 30 Jun 20218 earlier quartersnormal: $632.0M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Layoff notices: WARN layoff notice became public on 1 Sep 2021

Idexx Laboratories filed a WARN layoff notice covering 68 workers within 30 days (Totowa, NJ).

Notices in the window
1
Workers named
68
Window
2 Aug 2021 to 1 Sep 2021

Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

Short interest and volume: Short interest spike became public on 25 Sep 2021

Idexx Laboratories had 1.3M shares sold short in the 15 Sep 2021 report, 1.0× the same report last year.

This period
1.3M (the 15 Sep 2021 report)
Normal report (median of 24 earlier)
839K
Typical spread (median absolute deviation)
58K
How far from its usual level
+4.9
Same report last year
1.2M
History used
1,356 days
2020-09-15: 1.2M2020-09-30: 1.2M2020-10-15: 1.1M2020-10-30: 919K2020-11-13: 1.0M2020-11-30: 823K2020-12-15: 685K2020-12-31: 773K2021-01-15: 700K2021-01-29: 803K2021-02-12: 789K2021-02-26: 821K2021-03-15: 854K2021-03-31: 824K2021-04-15: 739K2021-04-30: 740K2021-05-14: 701K2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M
the 15 Sep 2021 report24 earlier reportsnormal: 839K

Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

Check it at the source: FINRA short interest data.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 13 May 2026Institutional holdings record

    Capital World Investors opened a $280.0M position (2026Q1 13F)

  2. 26 Mar 2026Filings record

    Director or officer change

  3. 13 Feb 2026Filings record

    Director or officer change

  4. 13 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  5. 13 Jan 2026Filings record

    Director or officer change

  6. 7 Oct 2025Filings record

    Director or officer change

  7. 14 Aug 2025Institutional holdings change

    saw 175 13F filers open a new position in the quarter ended 30 Jun 2025, 2.6× the same quarter last year.

    Same quarter last year: 68; its normal quarter is 78.5.

    See the evidence
    This period
    175 (the quarter ended 30 Jun 2025)
    Normal quarter (median of 8 earlier)
    78.5
    Typical spread (median absolute deviation)
    9
    How far from its usual level
    +7.2
    Same quarter last year
    68
    History used
    4,291 days
    2023-06-30: 682023-09-30: 712023-12-31: 1082024-03-31: 752024-06-30: 682024-09-30: 822024-12-31: 862025-03-31: 992025-06-30: 175
    the quarter ended 30 Jun 20258 earlier quartersnormal: 78.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  8. 13 Aug 2025Institutional holdings record

    POLEN CAPITAL MANAGEMENT LLC opened a $641.0M position (2025Q2 13F)

  9. 7 Aug 2025Institutional holdings record

    GENERATION INVESTMENT MANAGEMENT LLP opened a $304.0M position (2025Q2 13F)

  10. 10 Jul 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  11. 10 Jul 2025Filings record

    Director or officer change

  12. 14 Feb 2025Filings record

    Director or officer change

  13. 12 Dec 2024Filings record

    Director or officer change

  14. 21 Nov 2024Filings record

    Director or officer change

  15. 12 Nov 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  16. 12 Nov 2024Filings record

    Director or officer change

  17. 10 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 10 May 2024Filings record

    Director or officer change

  19. 7 Dec 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  20. 7 Dec 2023Filings record

    Director or officer change

  21. 13 Nov 2023Institutional holdings record

    GQG Partners LLC opened a $407.0M position (2023Q3 13F)

  22. 12 Jul 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 12 Jul 2023Filings record

    Director or officer change

  24. 25 Aug 2022Short interest and volume change

    had 2.0M shares sold short in the 15 Aug 2022 report, 2.3× the same report last year.

    Same report last year: 853K; its normal report is 869K.

    See the evidence
    This period
    2.0M (the 15 Aug 2022 report)
    Normal report (median of 24 earlier)
    869K
    Typical spread (median absolute deviation)
    158K
    How far from its usual level
    +4.7
    Same report last year
    853K
    History used
    1,690 days
    2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M2022-06-15: 2.0M2022-06-30: 2.0M2022-07-15: 1.9M2022-07-29: 1.7M2022-08-15: 2.0M
    the 15 Aug 2022 report24 earlier reportsnormal: 869K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  25. 10 Aug 2022Short interest and volume change

    had 1.7M shares sold short in the 29 Jul 2022 report, 2.0× the same report last year.

    Same report last year: 843K; its normal report is 865K.

    See the evidence
    This period
    1.7M (the 29 Jul 2022 report)
    Normal report (median of 24 earlier)
    865K
    Typical spread (median absolute deviation)
    146K
    How far from its usual level
    +3.6
    Same report last year
    843K
    History used
    1,673 days
    2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M2022-06-15: 2.0M2022-06-30: 2.0M2022-07-15: 1.9M2022-07-29: 1.7M
    the 29 Jul 2022 report24 earlier reportsnormal: 865K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 27 Jul 2022Short interest and volume change

    had 1.9M shares sold short in the 15 Jul 2022 report, 2.2× the same report last year.

    Same report last year: 878K; its normal report is 849K.

    See the evidence
    This period
    1.9M (the 15 Jul 2022 report)
    Normal report (median of 24 earlier)
    849K
    Typical spread (median absolute deviation)
    125K
    How far from its usual level
    +5.6
    Same report last year
    878K
    History used
    1,659 days
    2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M2022-06-15: 2.0M2022-06-30: 2.0M2022-07-15: 1.9M
    the 15 Jul 2022 report24 earlier reportsnormal: 849K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 13 Jul 2022Short interest and volume change

    had 2.0M shares sold short in the 30 Jun 2022 report, 2.4× the same report last year.

    Same report last year: 835K; its normal report is 849K.

    See the evidence
    This period
    2.0M (the 30 Jun 2022 report)
    Normal report (median of 24 earlier)
    849K
    Typical spread (median absolute deviation)
    119K
    How far from its usual level
    +6.4
    Same report last year
    835K
    History used
    1,644 days
    2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M2022-06-15: 2.0M2022-06-30: 2.0M
    the 30 Jun 2022 report24 earlier reportsnormal: 849K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 28 Jun 2022Short interest and volume change

    had 2.0M shares sold short in the 15 Jun 2022 report, 2.3× the same report last year.

    Same report last year: 852K; its normal report is 849K.

    See the evidence
    This period
    2.0M (the 15 Jun 2022 report)
    Normal report (median of 24 earlier)
    849K
    Typical spread (median absolute deviation)
    94K
    How far from its usual level
    +7.9
    Same report last year
    852K
    History used
    1,629 days
    2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M2022-06-15: 2.0M
    the 15 Jun 2022 report24 earlier reportsnormal: 849K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 10 Jun 2022Short interest and volume change

    had 1.8M shares sold short in the 31 May 2022 report, 2.1× the same report last year.

    Same report last year: 860K; its normal report is 844K.

    See the evidence
    This period
    1.8M (the 31 May 2022 report)
    Normal report (median of 24 earlier)
    844K
    Typical spread (median absolute deviation)
    90K
    How far from its usual level
    +7.3
    Same report last year
    860K
    History used
    1,614 days
    2021-05-14: 701K2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M2022-05-31: 1.8M
    the 31 May 2022 report24 earlier reportsnormal: 844K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  30. 25 May 2022Short interest and volume change

    had 1.4M shares sold short in the 13 May 2022 report, 2.0× the same report last year.

    Same report last year: 701K; its normal report is 842K.

    See the evidence
    This period
    1.4M (the 13 May 2022 report)
    Normal report (median of 24 earlier)
    842K
    Typical spread (median absolute deviation)
    85K
    How far from its usual level
    +4.5
    Same report last year
    701K
    History used
    1,596 days
    2021-04-30: 740K2021-05-14: 701K2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M2021-09-30: 794K2021-10-15: 735K2021-10-29: 723K2021-11-15: 700K2021-11-30: 629K2021-12-15: 886K2022-01-14: 725K2022-01-31: 841K2022-02-15: 773K2022-02-28: 787K2022-03-15: 845K2022-03-31: 1.0M2022-04-14: 1.1M2022-04-29: 1.2M2022-05-13: 1.4M
    the 13 May 2022 report24 earlier reportsnormal: 842K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 19 Jan 2022Lobbying record

    IDEXX: lobbying engagement terminated (COZEN O'CONNOR PUBLIC STRATEGIES) (dated 31 Oct 2021)

  32. 25 Sep 2021Short interest and volume change

    had 1.3M shares sold short in the 15 Sep 2021 report, 1.0× the same report last year.

    Same report last year: 1.2M; its normal report is 839K.

    See the evidence
    This period
    1.3M (the 15 Sep 2021 report)
    Normal report (median of 24 earlier)
    839K
    Typical spread (median absolute deviation)
    58K
    How far from its usual level
    +4.9
    Same report last year
    1.2M
    History used
    1,356 days
    2020-09-15: 1.2M2020-09-30: 1.2M2020-10-15: 1.1M2020-10-30: 919K2020-11-13: 1.0M2020-11-30: 823K2020-12-15: 685K2020-12-31: 773K2021-01-15: 700K2021-01-29: 803K2021-02-12: 789K2021-02-26: 821K2021-03-15: 854K2021-03-31: 824K2021-04-15: 739K2021-04-30: 740K2021-05-14: 701K2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M
    the 15 Sep 2021 report24 earlier reportsnormal: 839K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 1 Sep 2021several at once

    reported revenue of $826.1M for the quarter ended 30 Jun 2021, 1.3× the same quarter last year; it also filed a WARN layoff notice covering 68 workers within 30 days (Totowa, NJ); and it had 1.3M shares sold short in the 15 Sep 2021 report, 1.0× the same report last year. Three unrelated kinds of activity within 56 days.

    See the evidence (3 changes)

    Financials: Quarterly revenue change became public on 3 Aug 2021

    Idexx Laboratories reported revenue of $826.1M for the quarter ended 30 Jun 2021, 1.3× the same quarter last year.

    This period
    $826.1M (the quarter ended 30 Jun 2021)
    Normal quarter (median of 8 earlier)
    $632.0M
    Typical spread (median absolute deviation)
    $26.6M
    How far from its usual level
    +3.1
    Same quarter last year
    $637.6M
    History used
    4,383 days
    2019-06-30: $620.1M2019-09-30: $605.3M2019-12-31: $605.4M2020-03-31: $626.3M2020-06-30: $637.6M2020-09-30: $721.8M2020-12-31: $720.9M2021-03-31: $777.7M2021-06-30: $826.1M
    the quarter ended 30 Jun 20218 earlier quartersnormal: $632.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Layoff notices: WARN layoff notice became public on 1 Sep 2021

    Idexx Laboratories filed a WARN layoff notice covering 68 workers within 30 days (Totowa, NJ).

    Notices in the window
    1
    Workers named
    68
    Window
    2 Aug 2021 to 1 Sep 2021

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

    Short interest and volume: Short interest spike became public on 25 Sep 2021

    Idexx Laboratories had 1.3M shares sold short in the 15 Sep 2021 report, 1.0× the same report last year.

    This period
    1.3M (the 15 Sep 2021 report)
    Normal report (median of 24 earlier)
    839K
    Typical spread (median absolute deviation)
    58K
    How far from its usual level
    +4.9
    Same report last year
    1.2M
    History used
    1,356 days
    2020-09-15: 1.2M2020-09-30: 1.2M2020-10-15: 1.1M2020-10-30: 919K2020-11-13: 1.0M2020-11-30: 823K2020-12-15: 685K2020-12-31: 773K2021-01-15: 700K2021-01-29: 803K2021-02-12: 789K2021-02-26: 821K2021-03-15: 854K2021-03-31: 824K2021-04-15: 739K2021-04-30: 740K2021-05-14: 701K2021-05-28: 860K2021-06-15: 852K2021-06-30: 835K2021-07-15: 878K2021-07-30: 843K2021-08-13: 853K2021-08-31: 1.1M2021-09-15: 1.3M
    the 15 Sep 2021 report24 earlier reportsnormal: 839K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  34. 1 Sep 2021Layoff notices change

    filed a WARN layoff notice covering 68 workers within 30 days (Totowa, NJ).

    See the evidence (1 source record)
    Notices in the window
    1
    Workers named
    68
    Window
    2 Aug 2021 to 1 Sep 2021

    Fires on a WARN notice after 30 days without one; notices within 30 days are summed.

  35. 1 Sep 2021Layoff notices record

    WARN notice: IDEXX Laboratories, 68 workers, Totowa, NJ (dated 1 Aug 2021)

  36. 3 Aug 2021Financials change

    reported revenue of $826.1M for the quarter ended 30 Jun 2021, 1.3× the same quarter last year.

    Same quarter last year: $637.6M; its normal quarter is $632.0M.

    See the evidence
    This period
    $826.1M (the quarter ended 30 Jun 2021)
    Normal quarter (median of 8 earlier)
    $632.0M
    Typical spread (median absolute deviation)
    $26.6M
    How far from its usual level
    +3.1
    Same quarter last year
    $637.6M
    History used
    4,383 days
    2019-06-30: $620.1M2019-09-30: $605.3M2019-12-31: $605.4M2020-03-31: $626.3M2020-06-30: $637.6M2020-09-30: $721.8M2020-12-31: $720.9M2021-03-31: $777.7M2021-06-30: $826.1M
    the quarter ended 30 Jun 20218 earlier quartersnormal: $632.0M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  37. 10 Feb 2021Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 10 Feb 2021Filings record

    Director or officer change

  39. 12 Nov 2020Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 12 Nov 2020Filings record

    Director or officer change

Showing the newest 40 of 68 entries; narrow the window or the kind of data to see older ones.

Not listed: 298 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0000874716
Ticker
IDXX
Domain
idexx.com
Employer name
IDEXX LABORATORIES, INC. (1 unverified)
Hq location
ME|WESTBROOK|04092 (1 unverified)
Lobbying client
idexx
Name
342 Saco Street, LLC, Beijing IDEXX Laboratories Co. Limited, IDEXX Animana B.V, IDEXX Brasil Laboratórios Ltda and 44 more
Uei
PYDEJTVUBKP8, UJTGU4PX3DN8
Wikidata
Q1758392
Wikipedia
Idexx Laboratories
  • DOL H-1B labor condition applications and PERM certifications592 data points21 Oct 2019 to 28 Sep 2026
  • Federal lobbying disclosures (LDA)2 records, 21 data points29 Jun 2020 to 31 Dec 2021
  • SEC Form 13F institutional holdings4 records, 481 data points30 Jun 2013 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)124 records29 Jan 2016 to 2 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1323 data points31 Dec 2007 to 28 Oct 2026
  • SEC Form 4 insider transactions208 records, 608 data points9 Feb 2016 to 5 Nov 2026
  • FINRA short interest (twice monthly)624 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards5934 data points18 Oct 2007 to 16 Nov 2026
  • WARN layoff notices (state labor agencies)1 record, 3 data points26 Jul 2021 to 1 Aug 2021
  • Wikipedia pageviews2882 data points1 Jan 2019 to 21 Nov 2026